28 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
39
Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.
University of Karachi
25
Synthesis, alkaline phosphatase inhibition studies and molecular docking of novel derivatives of 4-quinolones.
Universit£T Rostock
30
2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases.
Forman Christian College (A Chartered University)
4
Synthesis of benzofuran derivatives as selective inhibitors of tissue-nonspecific alkaline phosphatase: effects on cell toxicity and osteoblast-induced mineralization.
University of Lyon
21
Diarylsulfonamides and their bioisosteres as dual inhibitors of alkaline phosphatase and carbonic anhydrase: Structure activity relationship and molecular modelling studies.
Forman Christian College (A Chartered University)
23
Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Quaid-I-Azam University
54
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes.
Sanford-Burnham Medical Research Institute
5
Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests.
University of Lyon
21
Identification of novel chromone based sulfonamides as highly potent and selective inhibitors of alkaline phosphatases.
Forman Christian College (A Chartered University)
1
Triazolothiadiazoles and triazolothiadiazines--biologically attractive scaffolds.
Quaid-I-Azam University
14
Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases.
University of Li£Ge
36
Design and synthesis of selective inhibitors of placental alkaline phosphatase.
Human Biomolecular Research Institute
22
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).
Institute For Medical Research
37
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold.
Monash University
17
Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes.
University of Auckland
31
2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study.
Universit£T Rostock
35
Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor.
Sanford Burnham Prebys Medical Discovery Institute
28
Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery.
Abbottabad University of Science and Technology
11
Synthesis of sulfadiazinyl acyl/aryl thiourea derivatives as calf intestinal alkaline phosphatase inhibitors, pharmacokinetic properties, lead optimization, Lineweaver-Burk plot evaluation and binding analysis.
Quaid-I-Azam University
132
Bicyclic heterocyclic derivatives as MNK1 and MNK2 modulators and uses thereof
A*Star
9
Derivatives of 2-aminopyridine as adenosine A2B receptor antagonists and ligands of the melatonin MT3 receptors
Palobiofarma
47
Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
The Medicines Company (Leipzig)
10
Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors.
Beckman Research Institute of The City of Hope
3
Thiahomoisocitrate: a highly potent inhibitor of homoisocitrate dehydrogenase involved in the alpha-aminoadipate pathway.
Tokyo Institute of Technology
7
Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors.
Fujisawa Pharmaceutical
13
4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.
Irbm-Mrl